0001882178-21-000020.txt : 20211007 0001882178-21-000020.hdr.sgml : 20211007 20211007200530 ACCESSION NUMBER: 0001882178-21-000020 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211007 FILED AS OF DATE: 20211007 DATE AS OF CHANGE: 20211007 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ricciardi Lisa CENTRAL INDEX KEY: 0001418200 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40886 FILM NUMBER: 211313544 MAIL ADDRESS: STREET 1: C/O COGNITION THERAPEUTICS, INC STREET 2: 2500 WESTCHESTER AVENUE CITY: PURCHASE STATE: NY ZIP: 10577 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COGNITION THERAPEUTICS INC CENTRAL INDEX KEY: 0001455365 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 2403 SIDNEY STREET STREET 2: SUITE 261 CITY: PITTSBURGH STATE: PA ZIP: 15203 BUSINESS PHONE: 412-481-2210 MAIL ADDRESS: STREET 1: 2500 WESTCHESTER AVE CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: COGNITION THERAPUTICS INC DATE OF NAME CHANGE: 20090204 3 1 edgar.xml PRIMARY DOCUMENT X0206 3 2021-10-07 0 0001455365 COGNITION THERAPEUTICS INC CGTX 0001418200 Ricciardi Lisa C/O COGNITION THERAPEUTICS, INC., 2500 WESTCHESTER AVE., PURCHASE, NY 10577 1 1 0 0 CEO & President Stock Option (right to buy) 1.07 2029-09-29 Common Stock 20095 D Stock Option (right to buy) 1.07 2030-02-27 Common Stock 7729 D Stock Option (right to buy) 1.2 2030-06-01 Common Stock 896177 D Stock Option (right to buy) 1.2 2030-03-23 Common Stock 41737 D The options vest in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on September 29, 2019. The options vest in four (4) equal annual installments beginning on the first anniversary of the option's grant date. The option was granted on February 27, 2020. 25% of the shares underlying the option vest on the first anniversary of the option's grant date and the remaining 75% vest in equal monthly installments for the thirty-six (36) months thereafter. The option was granted on June 1, 2020. The option is fully vested. /s/ Lisa Ricciardi, Attorney-in-Fact 2021-10-07